250
Participants
Start Date
June 30, 2012
Primary Completion Date
July 31, 2016
Study Completion Date
August 31, 2016
Tolvaptan or Samsca
uncoated tablet, 30mg, once per day, for up to 7 days.
placebo or sugar pill
sugar pill
Drexel University College of Medicine, Philadelphia
University of Maryland, Baltimore
CV Group Central Lynchburg/Stroobants Heart Center, Lynchburg
Caromont Heart/Gaston Memorial Hospital, Gastonia
Duke Cardiology of Lumberton Research/Southeastern Regional Medical Cente, Lumberton
Emory University, Atlanta
University Cardiology Associates, LLC, Augusta
Mercer University School of Medicine, Macon
University of Florida Health Science Ctr. Jacksonville, Jacksonville
MIMA Century Research Associates, Melbourne
Jackson Memorial Hospital, Miami
University of Alabama at Birmingham, Birmingham
The Heart Center Research, Huntsville
Akron General Medical Center, Akron
The Sisters of Mercy of Hamilton, Ohio dba Mercy Hospital Fairfield, Fairfield
University of Cincinnati, Cincinnatti
Dayton Heart Center, Dayton
St. Vincent Medical Group, Indianapolis
CardioSpecialists Group, Munster
Crittenton Hospital Medical Center, Rochester
University of Wisconsin, Madison
Minneapolis Heart Institute, Minneapolis
Advocate Christ Medical Center, Oak Lawn
Advocate Medical Group - Oakbrook, Naperville
Bryan Heart Institute, Lincoln
Ochsner Medical Center, New Orleans
Louisiana Heart Center and Research, Slidell
Advanced Cardiovascular Specialists, Shreveport
Oklahoma Heart Hospital, Oklahoma City
The Heart Hospital Baylor Plano - Research Insititute, Plano
University of Texas Health Science Center, Houston
Greater Los Angeles VA Medical Center, Los Angeles
Tufts Medical Center, Boston
Lahey Hospital and Medical Center, Burlington
The Valley Hospital, Ridgewood
Memorial Hospital of RI, Pawtucket
The Miriam Hosptial, Providence
Lead Sponsor
Cardiovascular Clinical Sciences Inc
INDUSTRY